BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 9793832)

  • 21. Prostate-specific antigen testing in Ontario: reasons for testing patients without diagnosed prostate cancer.
    Bunting PS; Goel V; Williams JI; Iscoe NA
    CMAJ; 1999 Jan; 160(1):70-5. PubMed ID: 9934349
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Screening for prostate cancer: a comparison of urologists and primary care physicians.
    McKnight JT; Tietze PH; Adcock BB; Maxwell AJ; Smith WO; Nagy MC
    South Med J; 1996 Sep; 89(9):885-8. PubMed ID: 8790311
    [TBL] [Abstract][Full Text] [Related]  

  • 23. GP and patient predictors of PSA screening in Australian general practice.
    Gattellari M; Young JM; Ward JE
    Fam Pract; 2003 Jun; 20(3):294-303. PubMed ID: 12738699
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of the digital rectal examination as a screening test for prostate cancer. Rotterdam section of the European Randomized Study of Screening for Prostate Cancer.
    Schröder FH; van der Maas P; Beemsterboer P; Kruger AB; Hoedemaeker R; Rietbergen J; Kranse R
    J Natl Cancer Inst; 1998 Dec; 90(23):1817-23. PubMed ID: 9839522
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors prompting PSA-testing of asymptomatic men in a country with no guidelines: a national survey of general practitioners.
    Drummond FJ; Carsin AE; Sharp L; Comber H
    BMC Fam Pract; 2009 Jan; 10():3. PubMed ID: 19138385
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Breast cancer screening prior to cosmetic breast surgery: ASPS members' Adherence to American Cancer Society Guidelines.
    Selber JC; Nelson JA; Ashana AO; Bergey MR; Bristol MN; Sonnad SS; Serletti JM; Wu LC
    Plast Reconstr Surg; 2009 Nov; 124(5):1375-1385. PubMed ID: 20009821
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Comparison between 2 techniques of screening for prostatic carcinoma. Rectal exploration and transrectal ultrasonography vs. prostate specific antigen].
    Ciatto S; Bonardi R; Mazzotta A; Lombardi C; Santoni R; Cardini S; Zappa M
    Radiol Med; 1994 Oct; 88(4):453-7. PubMed ID: 7527916
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PSA testing for prostate cancer: an online survey of the views and reported practice of General Practitioners in the UK.
    Brett J; Watson E; Hewitson P; Bukach C; Edwards A; Elwyn G; Austoker J
    BMC Fam Pract; 2005 Jun; 6(1):24. PubMed ID: 15946386
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of prostate-specific antigen for prostate cancer screening in primary care practice.
    Williams RB; Boles M; Johnson RE
    Arch Fam Med; 1995 Apr; 4(4):311-5. PubMed ID: 7536091
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic value of percent free prostate-specific antigen: retrospective analysis of a population-based screening study with emphasis on men with PSA levels less than 3.0 ng/mL.
    Törnblom M; Norming U; Adolfsson J; Becker C; Abrahamsson PA; Lilja H; Gustafsson O
    Urology; 1999 May; 53(5):945-50. PubMed ID: 10223488
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors affecting prostate cancer screening behaviour in a discrete population of doctors at the University Hospital of the West Indies, Jamaica.
    McNaughton D; Aiken W; McGrowder D
    Asian Pac J Cancer Prev; 2011; 12(5):1201-5. PubMed ID: 21875267
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Primary care physicians' practice patterns and diabetic retinopathy. Current levels of care.
    Kraft SK; Marrero DG; Lazaridis EN; Fineberg N; Qiu C; Clark CM
    Arch Fam Med; 1997; 6(1):29-37. PubMed ID: 9003167
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rural physicians' perspectives on cervical and breast cancer screening: a gender-based analysis.
    Ahmad F; Stewart DE; Cameron JI; Hyman I
    J Womens Health Gend Based Med; 2001 Mar; 10(2):201-8. PubMed ID: 11268303
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cancer screening guideline preference surveys: physicians' perceptions of the American Cancer Society.
    Hamblin J; Connor PD
    Tenn Med; 1998 Jan; 91(1):17-20. PubMed ID: 9439181
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Revisiting Prostate Cancer Screening Practices Among Vermont Primary Care Physicians.
    Donnelly L; Sternberg KM; Ashikaga T; Plante MK; Perrapato SD
    J Community Health; 2018 Feb; 43(1):33-37. PubMed ID: 28620736
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Childhood vaccine risk/benefit communication in private practice office settings: a national survey.
    Davis TC; Fredrickson DD; Arnold CL; Cross JT; Humiston SG; Green KW; Bocchini JA
    Pediatrics; 2001 Feb; 107(2):E17. PubMed ID: 11158491
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Specialty differences and the ordering of screening mammography by primary care physicians.
    Taplin SH; Taylor V; Montano D; Chinn R; Urban N
    J Am Board Fam Pract; 1994; 7(5):375-86. PubMed ID: 7810354
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Use of prostatic specific antigen in primary care (PSA)].
    Panach-Navarrete J; Gironés-Montagud A; Sánchez-Cano E; Doménech-Pérez C; Martínez-Jabaloyas JM
    Semergen; 2017 Apr; 43(3):189-195. PubMed ID: 27344583
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Experience with an assay for prostate-specific antigen and transrectal ultrasonography in the diagnosis of prostate cancer.
    Heman-Ackah CA; Festenstein JB; Hibbert P; Harvey DJ; Bunce CJ; Gelister JS
    Br J Urol; 1997 Mar; 79(3):439-44. PubMed ID: 9117228
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Why do patients of female physicians have higher rates of breast and cervical cancer screening?
    Lurie N; Margolis KL; McGovern PG; Mink PJ; Slater JS
    J Gen Intern Med; 1997 Jan; 12(1):34-43. PubMed ID: 9034944
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.